Skip to main content

Table 2 Comparison between the different studied groups to control group according to native T1 values

From: Could native T1 mapping replace late gadolinium enhancement in the assessment of myocardial fibrosis in patients with cardiomyopathy?

Segment HCM (n = 192) DCM (n = 800) AMYLOIDOSIS (n = 80) Normal case (n = 160) (p)
Anterior basal 1052.6 ± 41.77 1085.3# ± 81.33 1174.7# ± 137.0 1015.7 ± 39.61 0.018*
Antseptal base 1081.5 ± 51.79 1101.5# ± 83.88 1128.3 ± 66.26 1036.1 ± 29.17 0.044*
Infseptal base 1092.3 ± 63.96 1104.3# ± 82.05 1107.0 ± 39.95 1034.3 ± 35.57 0.032*
Inferior base 1037.1 ± 31.87 1093.2# ± 66.79 1146.7# ± 51.62 1012.9 ± 45.37 <0.001*
Inferolat base 1045.1 ± 39.62 1095.4# ± 60.99 1147.3# ± 57.05 987.7 ± 81.10 <0.001*
Anterolateral base 1039.7 ± 31.10 1087.9# ± 72.69 1132.0# ± 79.64 1019.5 ± 40.20 0.003*
Anterior MID 1047.3 ± 39.28 1075.9# ± 67.76 1169.7# ± 131.39 1011.8 ± 92.07 0.024*
Anteroseptal MID 1069.6# ± 33.89 1093.0# ± 67.62 1143.0# ± 101.95 1055.9 ± 29.0 <0.001*
Inferoseptal MID 1081.8# ± 36.85 1083.9# ± 52.19 1109.3 ± 51.63 1022.0 ± 63.0 0.004*
Inferior MID 1037.1 ± 31.0 1081.9# ± 55.70 1130.3# ± 93.36 1012.2 ± 64.99 <0.001*
Inferolateral MID 1031.3 ± 24.94 1086.2# ± 67.72 806.3 ± 581.74 1007.4 ± 46.05 <0.001*
Anterolateral MID 967.4 ± 257.3 1064.7 ± 55.86 1096.3 ± 63.97 1021.7 ± 57.31 0.041*
Anterior apex 1036.8 ± 21.82 1081.8# ± 71.79 1090.0 ± 59.23 1009.9 ± 69.26 0.004*
Septal APX 1058.9 ± 40.02 1094.6# ± 76.56 1073.7 ± 49.57 1020.5 ± 64.7 0.009*
Inferior apex 1056.0 ± 42.31 1082.4# ± 72.98 1135.0# ± 67.02 1016.4 ± 28.28 0.013*
Lateral apex 1050.4 ± 24.37 1080.9# ± 65.09 1100.3 ± 120.67 1014.2 ± 85.1 0.010*
Average 1049.1 ± 23.71 1100.9# ± 110.5 1105.6# ± 1105.6 1015.5 ± 20.88 0.019*
  1. F: F for ANOVA test, Pairwise comparison bet. each 2 groups was done using Post Hoc Test (Tukey)
  2. p: p value for comparing between the studied groups
  3. #: Significant with Normal case
  4. *: Statistically significant at p ≤ 0.05